Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Neurology

Survivorship, Follow-up, and Quality of Life

At a Glance

Vestibular schwannoma survivorship requires lifelong MRI monitoring to track tumor stability. Overall quality of life is similar regardless of treatment choice. Long-term care focuses on managing single-sided deafness, balance issues, and hidden nerve symptoms like eye dryness and taste changes.

Living with or after a vestibular schwannoma (VS) is a long-term journey. Whether you are observing a small tumor or recovering from active treatment, focus shifts from “fixing the problem” to maintaining your quality of life and monitoring for changes.

Monitoring Your Progress

Because these tumors are slow-growing, lifelong surveillance is often necessary to ensure the tumor remains stable [1].

  • The Follow-up Schedule: While protocols vary, patients in a wait-and-scan phase typically receive MRIs every 6 to 12 months initially [2]. After surgery or radiosurgery, scans may eventually be spaced out to every few years if the tumor shows no growth, but “gold standard” monitoring via MRI continues for a decade or more [3][1].
  • Regrowth Risk: If a surgeon performs a subtotal resection (intentionally leaving a small piece of tumor to protect the facial nerve), there is a risk the residual piece could grow [4]. Similarly, while Stereotactic Radiosurgery (SRS) has high control rates, a small percentage of tumors may still show progression [5]. Factors like the initial tumor volume and its pretreatment growth rate help doctors predict this risk [5][6].

Measuring Your Quality of Life (PANQOL)

To help doctors understand how the condition affects your daily life, researchers developed the Penn Acoustic Neuroma Quality of Life (PANQOL) scale [7]. This tool measures several areas:

  1. Hearing: Asymmetric or bilateral hearing loss is often the biggest driver of a lower quality of life [8].
  2. Balance: Dizziness and unsteadiness can have a heavy emotional impact, making social situations or physical activity more difficult [9][10].
  3. Facial Function: Concerns about facial symmetry can affect self-image and social confidence [11].
  4. General Health: This includes energy levels and the impact of chronic symptoms like headaches [11].

Research consistently shows that, in the long run, overall quality of life scores are similar whether you choose surgery, radiation, or observation [12][13][14]. This means that no single path is “better” for your happiness—the best choice is the one that aligns with your personal priorities.

Under-Recognized Long-Term Symptoms

Beyond hearing and balance, several “hidden” side effects can impact your recovery:

  • Taste Disturbances: Damage or irritation to the nervus intermedius (a part of the facial nerve complex located near the tumor) can cause a metallic taste or a loss of taste on one side of the tongue [15][16].
  • Eye Dryness: If the facial nerve is weak, you may not blink as often or as fully, leading to chronic eye dryness and potential vision issues [16][17].
  • Chronic Headaches: Postoperative headaches are a common challenge, especially following certain surgical approaches [11].
  • Trigeminal Symptoms: Particularly after radiation, some patients may experience facial numbness or tingling if the tumor presses on the nearby trigeminal nerve [18][19].

Strategies for Thriving

Managing your long-term health involves more than just scans.

  • Managing Single-Sided Deafness (SSD): If you lose hearing in one ear, specialized devices like CROS hearing aids or Bone-Anchored Hearing Aids (BAHA) can capture sound from your “deaf” side and route it to your hearing ear, significantly improving your spatial awareness and quality of life [20].
  • Vestibular Rehabilitation: Continuing with balance exercises can help the brain maintain its “retraining,” especially if you experience occasional dizzy spells [21][22].
  • Managing Scan Anxiety: “Scan-xiety” is real. Working with your team to get results quickly or using relaxation techniques before an MRI can help manage the stress of lifelong monitoring.
  • Specialized Care: If you experience eye dryness or taste changes, don’t ignore them. Specialists like oculoplastic surgeons or neurologists can offer treatments to protect your vision and manage nerve-related pain [17][23].

Common questions in this guide

What is the typical MRI follow-up schedule for a vestibular schwannoma?
Patients usually need an MRI every 6 to 12 months initially. After treatment, scans may be spaced out to every few years, but lifelong monitoring is generally recommended to ensure the tumor does not grow or change.
Can a vestibular schwannoma grow back after treatment?
Yes, there is a small risk of regrowth, particularly if a piece of the tumor was intentionally left during surgery to protect your facial nerve. Tumors treated with stereotactic radiosurgery can also occasionally show progression over time.
Will my quality of life be better if I choose surgery instead of radiation?
Research shows that long-term quality of life is very similar regardless of whether you choose surgery, radiation, or observation. The best treatment choice depends on your specific tumor and personal priorities rather than a guaranteed better outcome for one method.
Why do I have a metallic taste in my mouth after vestibular schwannoma treatment?
A metallic taste or loss of taste can happen if the nervus intermedius is damaged or irritated. This nerve is part of the facial nerve complex located very close to where the tumor grows.
How can I manage hearing loss in one ear from my tumor?
Single-sided deafness can be managed with specialized devices like CROS hearing aids or Bone-Anchored Hearing Aids (BAHA). These devices capture sound from your deaf side and route it to your working ear, which helps improve your spatial awareness.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my specific MRI follow-up schedule for the next five to ten years?
  2. 2.If I have a residual tumor after surgery, what are the specific signs that it might be regrowing?
  3. 3.Are my headaches or balance issues expected at this stage of recovery, or should we adjust my treatment plan?
  4. 4.Can you refer me to a specialist for my eye dryness or taste changes?
  5. 5.Am I a candidate for a CROS or bone-anchored hearing aid (BAHA) to help with my single-sided deafness?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Malignant transformation of vestibular schwannoma after radiation therapy.

    Drakos A, Goncalves Filho A, Woulfe J, et al.

    Radiology case reports 2024; (19(7)):2654-2662 doi:10.1016/j.radcr.2024.03.033.

    PMID: 38645955
  2. 2

    De Novo Vestibular Schwannoma: A Report of Three Cases.

    Kubota M, Yamakami I, Kubota S, Higuchi Y

    NMC case report journal 2019; (6(2)):47-50 doi:10.2176/nmccrj.cr.2018-0188.

    PMID: 31016100
  3. 3

    The Diagnostic Accuracy of Pure-Tone Audiometry Screening Protocols for Vestibular Schwannoma in Patients with Asymmetrical Hearing Loss-A Systematic Review and Meta-Analysis.

    Gheorghe L, Negru D, Cobzeanu MD, et al.

    Diagnostics (Basel, Switzerland) 2022; (12(11)) doi:10.3390/diagnostics12112776.

    PMID: 36428836
  4. 4

    Evolving Role of Non-Total Resection in Management of Acoustic Neuroma in the Gamma Knife Era.

    Luryi AL, Kveton JF, Babu S, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2020; (41(10)):e1354-e1359 doi:10.1097/MAO.0000000000002904.

    PMID: 33492813
  5. 5

    Predictors of Growth of Vestibular Schwannoma After Gamma Knife Treatment: A Systematic Review.

    Yang C, Alvarado D, Ravindran PK, et al.

    Cancers 2025; (17(12)) doi:10.3390/cancers17121993.

    PMID: 40563642
  6. 6

    Tumor Control Following Stereotactic Radiosurgery in Patients with Vestibular Schwannomas - A Retrospective Cohort Study.

    Santa Maria PL, Shi Y, Aaron KA, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2021; (42(10)):e1548-e1559 doi:10.1097/MAO.0000000000003285.

    PMID: 34353978
  7. 7

    Validation and multidimensional analysis of the japanese penn acoustic neuroma quality-of-life scale.

    Nishiyama T, Oishi N, Kojima T, et al.

    The Laryngoscope 2020; (130(12)):2885-2890 doi:10.1002/lary.28488.

    PMID: 31922264
  8. 8

    Hearing rehabilitation in patients with vestibular schwannomas.

    Lloyd SKW, Trudel M, A Rutherford S, Behr R

    Handbook of clinical neurology 2025; (212()):381-394 doi:10.1016/B978-0-12-824534-7.00033-0.

    PMID: 41052861
  9. 9

    Vestibular Function and Complaints in Patients With Untreated Unilateral Vestibular Schwannoma.

    Fuentealba Bassaletti C, van Esch BF, van Lieshout K, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2025; (46(10)):e519-e525 doi:10.1097/MAO.0000000000004661.

    PMID: 41094710
  10. 10

    Vestibular Complaints Impact on the Long-Term Quality of Life of Vestibular Schwannoma Patients.

    Fuentealba-Bassaletti C, Neve OM, van Esch BF, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2023; (44(2)):161-167 doi:10.1097/MAO.0000000000003773.

    PMID: 36624597
  11. 11

    Quality of life in patients after vestibular schwannoma surgery.

    Lazak J, Betka J, Zverina E, et al.

    Acta neurochirurgica 2024; (166(1)):33 doi:10.1007/s00701-024-05936-z.

    PMID: 38270649
  12. 12

    Systematic review of disease-specific quality of life in patients with sporadic vestibular schwannoma.

    Khandalavala KR, Zalaquett NG, Lohse CM, et al.

    Journal of neuro-oncology 2025; (176(2)):136 doi:10.1007/s11060-025-05386-2.

    PMID: 41441907
  13. 13

    Long-Term Quality of Life of Vestibular Schwannoma Patients: A Longitudinal Analysis.

    Neve OM, Jansen JC, Koot RW, et al.

    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 2023; (168(2)):210-217 doi:10.1177/01945998221088565.

    PMID: 35349360
  14. 14

    Hearing and Quality of Life Over Time in Vestibular Schwannoma Patients: Observation Compared to Stereotactic Radiosurgery.

    Miller LE, Brant JA, Chen J, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2019; (40(8)):1094-1100 doi:10.1097/MAO.0000000000002334.

    PMID: 31335799
  15. 15

    Postoperative dysgeusia following microsurgical resection for acoustic neuroma: a systematic review and meta-analysis.

    Bangash AH, Khalid A, Chaurasia B

    Neurosurgical review 2024; (47(1)):536 doi:10.1007/s10143-024-02788-0.

    PMID: 39230764
  16. 16

    Long-Term Nervus Intermedius Function Outcomes and Their Predictors in Patients With Vestibular Schwannoma After Microsurgery.

    Geng H, Tang Y, Zhang B, et al.

    Neurosurgery 2026; (98(6)):1269-1277 doi:10.1227/neu.0000000000003774.

    PMID: 41036859
  17. 17

    The importance of simultaneous oculoplastic surgery in quality of life related to vision in surgical resection of large vestibular schwannomas.

    Asensi-Diaz M, Rodrigo Fernandez R, Aristegui Torrano I, et al.

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2025; (282(4)):1743-1750 doi:10.1007/s00405-024-09053-6.

    PMID: 39488598
  18. 18

    Stereotactic Radiosurgery in Primary Treatment of Sporadic Small to Medium (<3 cm) Vestibular Schwannomas: A Systematic Review and Meta-Analysis.

    Bonin BJ, Beckman S, Mahmud S, et al.

    World neurosurgery 2025; (194()):123304 doi:10.1016/j.wneu.2024.10.033.

    PMID: 39461420
  19. 19

    Audiovestibular symptoms and facial nerve function comparing microsurgery versus SRS for vestibular schwannomas: a systematic review and meta-analysis.

    Yakkala VK, Mammi M, Lamba N, et al.

    Acta neurochirurgica 2022; (164(12)):3221-3233 doi:10.1007/s00701-022-05338-z.

    PMID: 35962847
  20. 20

    Trends in hearing rehabilitation use among vestibular schwannoma patients.

    Drusin MA, Lubor B, Losenegger T, Selesnick S

    The Laryngoscope 2020; (130(6)):1558-1564 doi:10.1002/lary.28316.

    PMID: 31603544
  21. 21

    The evaluation of vestibular compensation by vestibular rehabilitation and prehabilitation in short-term postsurgical period in patients following surgical treatment of vestibular schwannoma.

    Hrubá S, Chovanec M, Čada Z, et al.

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2019; (276(10)):2681-2689 doi:10.1007/s00405-019-05503-8.

    PMID: 31187238
  22. 22

    The effect of intratympanic gentamicin as a prehabilitation strategy for objective and subjective vestibular function in patients undergoing microsurgery for a unilateral vestibular schwannoma.

    Fuentealba Bassaletti C, van Esch BF, Jansen JC, et al.

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2024; (281(1)):31-41 doi:10.1007/s00405-023-08240-1.

    PMID: 37750993
  23. 23

    Clinical practice guideline on the management of vestibular schwannoma.

    Lassaletta L, Acle Cervera L, Altuna X, et al.

    Acta otorrinolaringologica espanola 2024; (75(2)):108-128 doi:10.1016/j.otoeng.2023.10.005.

    PMID: 38346489

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or specialist about your specific follow-up schedule and symptom management.

Get notified when new evidence is published on Vestibular schwannoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.